BUSINESS● LOWSep 4 · Sep 4, 2026, 9:00 PM
Ionis Pharmaceuticals falls after Pelacarsen fails key Phase 3 heart trial
Seeking Alpha Tech · global
Ionis Pharmaceuticals experienced a decline after its drug Pelacarsen failed a key Phase 3 heart trial, impacting the company's market performance and drug development efforts.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS27m agoGombe community gets 1MW solar power plant after 17 years off national gridPremium TimesBUSINESS37m agoVettri Payanam scheme plunges auto and private bus operators into livelihood crisisThe Hindu